Märta Segerdahl

Chief Medical Officer

AstraZeneca (Sweden)

Sweden

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Märta Segerdahl is the Chief Medical Officer at AlzeCure Pharma in Sweden. Her research focuses on pain management, particularly in relation to the TRPV1 receptor antagonists and their effects on neuropathic pain. Recent articles authored by her include studies on the efficacy of ACD440 Gel in reducing temperature-evoked pain and sensory perception changes in patients with neuropathy.

Articles (3)

Year:

2025

Year:

2024

Year:

2021

Collaborators (1)

Per Hansson

Professor

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Märta Segerdahl

Explore related searches

Contact this professor

About

Articles (3)

Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover study

Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double‐blind, placebo‐controlled, crossover study

Contralateral Sensory and Pain Perception Changes in Patients With Unilateral Neuropathy.

Collaborators (1)

Per Hansson

Make your next move.